10-carboxymethyl-9-acridanone

Subscribe to Selected New Research on 10-carboxymethyl-9-acridanone

22 relevant articles (3 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd

Also Known As:

10(9H)-acridineacetic acid, 9-oxo-; 10-carboxymethyl-9-acridanone, sodium salt; 9-oxo-10-acridineacetic acid; acridone N-methyl-N-(alpha,D-glucopyranosyl)ammonium 10-methylenecarboxylate; cycloferon

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

3-Ring Heterocyclic Compounds

Acridines: 25

10-carboxymethyl-9-acridanone: 22

Experts

1.	Kovalenko, A L: 5 articles (11/2004 - 01/2000)
2.	Ershov, F I: 3 articles (11/2004 - 01/2000)
3.	Zarubaev, V V: 2 articles (09/2000 - 01/2000)
4.	Sukhinin, V P: 2 articles (09/2000 - 01/2000)
5.	Tarkhan-Mouravi, I D: 1 article (01/2007)
6.	Lomaia, M M: 1 article (01/2007)
7.	Sel'kova, E P: 1 article (11/2004)
8.	Zhekalov, A N: 1 article (11/2004)
9.	Garashchenko, T I: 1 article (11/2004)
10.	Petlenko, S V: 1 article (11/2004)

Related Diseases

1.	Infection 11/01/2004 - "The results of the placebo-controlled multicenter study of the epidemiological efficiency of the preparation Cycloferon for the prophylaxis of acute respiratory viral infections in children and adolescents are presented" 07/01/2003 - "In generalized herpes infection in non-inbred white mice with undamaged immune status cycloferon increased survival rate by 30-100% in comparison with the controls (untreated mice), while in case of immunosuppression the protective effect of this preparation was considerably lower" 07/01/2003 - "Cytokinin inducing and antiviral activity of cycloferon on experimental herpetic infection]" 03/01/2004 - "The use of the latter concurrently with cycloferon for the treatment of infections provoked by herpes simple virus-1 (HSV-1) and HSV-2 in HIV-infected patients prolongs the remission period in case of the above opportunistic infections" 11/01/2004 - "Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]" Order ALL the reference details at left...
2.	Human Influenza (Influenza) 09/01/2000 - "Protective effect of granulated cycloferon has been studied in albino mice infected with influenza" 09/01/2000 - "Protective effect of cycloferon in experimental influenza]" 11/01/2004 - "Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]" 02/01/2001 - "Cycloferon, Larifan, and Kagocel, which induce IFN formation in lungs, may be effective against influenza and rhinoviral infections" Order ALL the reference details at left...
3.	Peptic Ulcer (Peptic Ulcers) 03/01/2004 - "Efficacy of cycloferon and erbisol in the complex surgical treatment of multiple gastroduodenal ulcers]" 03/01/2004 - "The blood immune indexes normalization was promoted by cycloferon and erbisol incorporation in complex of surgical treatment of multiple gastroduodenal ulcers" Order ALL the reference details at left...
4.	Opportunistic Infections (Opportunistic Infection) 03/01/2004 - "The use of the latter concurrently with cycloferon for the treatment of infections provoked by herpes simple virus-1 (HSV-1) and HSV-2 in HIV-infected patients prolongs the remission period in case of the above opportunistic infections" Order ALL the reference details at left...
5.	Hepatitis B 02/01/2001 - "Cycloferon and Larifan stimulate IFN production in liver and spleen and may be effective against hepatitis B" Order ALL the reference details at left...

Related Drugs and Biologics

1.	erbisol
2.	larifan
3.	Interferons
4.	Tilorone (Tilorone Hydrochloride)
5.	Cyclophosphamide (Cytoxan)
6.	Messenger RNA (mRNA)
7.	Dimethoate (Rogor)
8.	Actihaemyl
9.	thymogen
10.	poludan

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 13878 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>